Urinary PGE-M Levels and Risk of Ovarian Cancer.

Mollie E BarnardAlicia Beeghly-FadielGinger L MilneEftitan Y AkamAndrew T ChanA Heather EliassenBernard A RosnerXiao-Ou ShuKathryn L TerryYong-Bing XiangWei ZhengShelley T Tworoger

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

Systemic prostaglandin levels do not appear strongly associated with ovarian cancer risk. Future research into aspirin use and ovarian cancer risk should consider local prostaglandins and prostaglandin-independent mechanisms.

Keyphrases

low dose
cardiovascular events
current status
type diabetes
coronary artery disease